Skip to Content
Merck
CN

AVG-16

6062701, pig ovary (follicle), Fibroblast

Synonym(s):

AVG 16, AVG(16), AVG16

Sign Into View Organizational & Contract Pricing

Select a Size


About This Item

UNSPSC Code:
41106514
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

AVG-16, 06062701, from pig ovary(follicle)

biological source

pig ovary (follicle)

growth mode

Not specified

karyotype

2n=38

morphology

Fibroblast

products

Not specified

receptors

Not specified

technique(s)

cell culture | mammalian: suitable

shipped in

dry ice

Biochem/physiol Actions

AVG-16 consists of reversibly immortalised primary granulosa cells. Primary cultures of pig granulosa cells have been cultured in the presence of the media supplement Ovagrow-S2A resulting in the establishment of an immortalised porcine primary granulosa cell line. Ovagrow-S2A, produced by Aivogen, comprises a naturally derived complex of growth promoting compounds, carrier proteins, and factors. These cells are not contact inhibited. The cells are conditionally immortalised; cell death will occur in the absence of OvagrowS2A and/or fibroblast growth factor-basic (bFGF).
Not specified
Porcine Reversibly Immortalised Primary Granulosa Cells

Preparation Note

DMEM + 2 mM Glutamine + 10% Fetal Bovine Serum (FBS) + 1% NEAA + 2.5ng/ml Fibroblast Growth Factor-Basic (bFGF) + 4% OvagrowS2A
Split subconfluent cultures (70-80%) 1:5 to 1:10, i.e., seeding at 2-4x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37 °C. Saturation density: 1.5x100,000 cells/cm2.

Other Notes

Cultures from HPA Culture Collections and supplied by Sigma are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.

Legal Information

Patent publication No is WO2005021737

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service